Contineum Therapeutics, Inc. company insiders have only been selling lately: three insiders trimmed about $1.9 million of stock over 12 months, with no open-market purchases.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
102 investment managers listed CTNM in their latest 13F filings (Q2 2026); more funds bought than sold. 4 quarters in a row of net selling by insiders. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Stengone Carmine N. | CEO | Sell | 2,500 | $16.46 | $41K | SEC |
| Aug 3, 2026 | Stengone Carmine N. | CEO | Sell | 2,500 | $16.01 | $40K | SEC |
| Jul 10, 2026 | Lorrain Daniel S. | Executive Officer | Sell | 25 | $16.00 | $400 | SEC |
| Jul 10, 2026 | Lorrain Daniel S. | Executive Officer | Sell | 1,015 | $16.00 | $16K | SEC |
| Jul 8, 2026 | Stengone Carmine N. | CEO | Sell | 2,500 | $16.00 | $40K | SEC |
| Jul 2, 2026 | Lorrain Daniel S. | Executive Officer | Sell | 2,501 | $16.24 | $41K | SEC |
| Jul 2, 2026 | Lorrain Daniel S. | Executive Officer | Sell | 5,852 | $15.67 | $92K | SEC |
| Jul 2, 2026 | Lorrain Daniel S. | Executive Officer | Sell | 28,826 | $16.04 | $462K | SEC |
| Jul 1, 2026 | Watkins Tim | Executive Officer | Sell | 10,833 | $16.02 | $174K | SEC |
| Jul 1, 2026 | Stengone Carmine N. | CEO | Sell | 10,000 | $16.01 | $160K | SEC |
| Jun 1, 2026 | Lorrain Daniel S. | Executive Officer | Sell | 4,170 | $13.16 | $55K | SEC |
| May 1, 2026 | Lorrain Daniel S. | Executive Officer | Sell | 300 | $13.84 | $4K | SEC |
| May 1, 2026 | Lorrain Daniel S. | Executive Officer | Sell | 3,870 | $13.06 | $51K | SEC |
| Apr 6, 2026 | Lorrain Daniel S. | Executive Officer | Sell | 4,170 | $13.43 | $56K | SEC |
| Mar 2, 2026 | Lorrain Daniel S. | Executive Officer | Sell | 4,170 | $15.01 | $63K | SEC |
In the last 12 months Contineum Therapeutics, Inc. insiders made open-market purchases worth about $0 and sales worth about $1.9 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in CTNM was filed on 2026-09-08.
102 investment managers reported holding CTNM in SEC Form 13F filings for Q2 2026.
No congressional trades in CTNM were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).